Search results
Showing 8146 to 8160 of 8981 results
Discontinued Reference number: GID-TA10208
Discontinued Reference number: GID-TA10168
Pelareorep for treating metastatic malignant melanoma after previous therapy [ID941]
Discontinued Reference number: GID-TA10686
Discontinued Reference number: GID-TA10689
Nivolumab with ipilimumab for neoadjuvant treatment of early non-small-cell lung cancer [ID3756]
Discontinued Reference number: GID-TA10631
Idasanutlin with cytarabine for treating relapsed or refractory acute myeloid leukaemia [ID1597]
Discontinued Reference number: GID-TA10494
Discontinued Reference number: GID-TA11179
Discontinued Reference number: GID-TA11177
Cardiovascular events (prevention, high risk) - anacetrapib [ID1164]
Discontinued Reference number: GID-TA11176
Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]
Discontinued Reference number: GID-HST10004
Rovalpituzumab tesirine for treating small-cell lung cancer after 2 therapies [ID1288]
Discontinued Reference number: GID-TA10212
Discontinued Reference number: GID-TA10186
Discontinued Reference number: GID-TA10473
Discontinued Reference number: GID-TA10284
Pembrolizumab with epacadostat for untreated malignant melanoma [ID1423]
Discontinued Reference number: GID-TA10330